These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35147643)

  • 1. Acromegalic cardiomyopathy: a neglected cause of cardiomyopathy.
    Bonora T; Rigamonti E; Capoferri M; De Perna ML
    Clin Ter; 2022 Feb; 173(1):31-34. PubMed ID: 35147643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acromegalic Cardiomyopathy: An Entity on its own? The Effects of GH and IGF-I Excess and Treatment on Cardiovascular Risk Factors.
    Wolf P; Maione L; Kamenický P; Chanson P
    Arch Med Res; 2023 Dec; 54(8):102921. PubMed ID: 38040526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic therapy and curative effect in pituitary adenoma patients complicated by acromegalic cardiomyopathy.
    Zhou H; Zha Z; Li X; Chen X; Wang J; Su Z
    Neurosurg Rev; 2018 Jul; 41(3):869-875. PubMed ID: 29238923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acromegalic cardiomyopathy: Epidemiology, diagnosis, and management.
    Sharma AN; Tan M; Amsterdam EA; Singh GD
    Clin Cardiol; 2018 Mar; 41(3):419-425. PubMed ID: 29574794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heart failure as a manifestation of acromegaly].
    Ságová I; Dragula M; Kantárová D; Vaňuga A; Vaňuga P
    Vnitr Lek; 2020; 66(4):82-86. PubMed ID: 32972190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acromegalic cardiomyopathy].
    Bencze A; Rácz K
    Orv Hetil; 2011 Nov; 152(47):1875-8. PubMed ID: 22042313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy.
    Colao A; Baldelli R; Marzullo P; Ferretti E; Ferone D; Gargiulo P; Petretta M; Tamburrano G; Lombardi G; Liuzzi A
    J Clin Endocrinol Metab; 2000 Jan; 85(1):193-9. PubMed ID: 10634386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acromegaly and it's cardiovascular implications].
    Cadena-Obando DA; Remba-Shapiro I; Abreu-Rosario CG; Mercado M
    Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):73-80. PubMed ID: 33667046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of juvenile acromegaly that was initially diagnosed as severe congestive heart failure from acromegaly-induced dilated cardiomyopathy.
    Sue M; Yoshihara A; Okubo Y; Ishikawa M; Ando Y; Hiroi N; Shibuya K; Yoshino G
    Intern Med; 2010; 49(19):2117-21. PubMed ID: 20930439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
    Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
    J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
    Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
    Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normalisation of plasma growth hormone levels improved cardiac dysfunction due to acromegalic cardiomyopathy with severe fibrosis.
    Yokota F; Arima H; Hirano M; Uchikawa T; Inden Y; Nagatani T; Oiso Y
    BMJ Case Rep; 2010 Sep; 2010():. PubMed ID: 22791498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac effect of thyrotoxicosis in acromegaly.
    Marzullo P; Cuocolo A; Ferone D; Pivonello R; Salvatore M; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1426-32. PubMed ID: 10770177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acromegalic cardiomyopathy: a review of the literature.
    Matta MP; Caron P
    Pituitary; 2003; 6(4):203-7. PubMed ID: 15237931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
    Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
    Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acromegalic Cardiomyopathy: An Overview of Risk Factors, Clinical Manifestations, and Therapeutic Options.
    Goldberg MD; Vadera N; Yandrapalli S; Frishman WH
    Cardiol Rev; 2018; 26(6):307-311. PubMed ID: 29794808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects.
    Colao A; Marzullo P; Spiezia S; Ferone D; Giaccio A; Cerbone G; Pivonello R; Di Somma C; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1986-91. PubMed ID: 10372698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
    Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.